EFDID: 139598EFD: View Filing

Issuer: Cynapsus Therapeutics Inc. (0001532079) - D

Accession: 0001532079-15-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001532079
  • Entity Name:
    Cynapsus Therapeutics Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    CANADA (FEDERAL LEVEL)
  • Year of Inc:
    Over 5 years ago
  • Address:
    828 RICHMOND STREET WEST
    TORONTO, A6 M6J 1C9
  • Persons:
    Related Persons 10
    Anthony Giovinazzo
    Executive Officer, Director
    Andrew Williams
    Executive Officer
    Tomer Gold
    Director
    Ronald Hosking
    Director
    Margaret Nan Hutchinson
    Director
    Perry Molinoff
    Director
    Ilan Oren
    Director
    Tamar D. Howson
    Director
    Rochelle Stenzler
    Director
    Thierry Bilbault
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    04/14/2015
  • First Sale Date:
    03/31/2015
  • Offering Amount:
    $16,750,000
  • Amount Sold:
    $16,750,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Noble Financial Capital Markets 15768 None None CA, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cynapsus Therapeutics Inc./s/ Andrew WilliamsAndrew WilliamsChief Operating Officer and Chief Financial Officer2015-04-10